Diamond Hill Capital Management LLC Investment Advisor Buys Shares of 475,941 Astrana Health, Inc. $ASTH

Key Points

• Diamond Hill Capital Management initiated a 475,941-share position in Astrana Health, valued at approximately $22.1 million and representing 0.85% of the company. Institutional investors collectively own 52.77% of ASTH.
• Astrana Health shares opened at $40.81, compared with a 52-week range of $18.08 to $51.60. The company has a $2.27 billion market capitalization and a price-to-earnings ratio of 49.77.
• Analysts remain broadly bullish, with seven Buy ratings and two Holds. The stock has a “Moderate Buy” consensus rating and a $49.43 average price target, while Truist and Barclays recently raised their targets to $55 and $53, respectively.

Diamond Hill Capital Management LLC Investment Advisor bought a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 475,941 shares of the company's stock, valued at approximately $22,088,000. Diamond Hill Capital Management LLC Investment Advisor owned 0.85% of Astrana Health as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Sei Investments Co. grew its holdings in Astrana Health by 94.4% during the first quarter. Sei Investments Co. now owns 134,899 shares of the company's stock valued at $3,308,000 after purchasing an additional 65,509 shares during the period. Principal Financial Group Inc. increased its position in Astrana Health by 15.7% in the first quarter. Principal Financial Group Inc. now owns 265,948 shares of the company's stock worth $6,521,000 after buying an additional 36,150 shares during the last quarter. Hussman Strategic Advisors Inc. raised its stake in shares of Astrana Health by 200.0% in the fourth quarter. Hussman Strategic Advisors Inc. now owns 63,000 shares of the company's stock valued at $1,563,000 after buying an additional 42,000 shares during the period. UBS Group AG raised its stake in shares of Astrana Health by 48.4% in the fourth quarter. UBS Group AG now owns 176,100 shares of the company's stock valued at $4,369,000 after buying an additional 57,432 shares during the period. Finally, Louisiana State Employees Retirement System purchased a new position in shares of Astrana Health during the 1st quarter valued at $468,000. Hedge funds and other institutional investors own 52.77% of the company's stock.

Astrana Health Price Performance

NASDAQ:ASTH opened at $40.81 on Monday. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of 49.77 and a beta of 0.87. Astrana Health, Inc. has a 52-week low of $18.08 and a 52-week high of $51.60. The stock has a fifty day moving average of $41.34 and a 200 day moving average of $32.87. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.23 and a current ratio of 1.23.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ASTH. Weiss Ratings raised Astrana Health from a "hold (c-)" rating to a "hold (c)" rating in a report on Monday, June 1st. Truist Financial upped their price objective on shares of Astrana Health from $47.00 to $55.00 and gave the company a "buy" rating in a report on Monday, August 10th. Needham & Company LLC increased their target price on shares of Astrana Health from $30.00 to $41.00 and gave the stock a "buy" rating in a research report on Friday, May 8th. Barclays boosted their price target on shares of Astrana Health from $50.00 to $53.00 and gave the company an "overweight" rating in a research report on Friday, August 7th. Finally, Robert W. Baird set a $45.00 price target on shares of Astrana Health in a research note on Friday, May 8th. Seven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Astrana Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $49.43.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source